v3.26.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 32,003 $ 50,200
General and administrative 14,089 14,991
Total operating expenses 46,092 65,191
Loss from operations (46,092) (65,191)
Other income (expenses), net:    
Interest and other income, net 3,573 5,516
Interest expense (300) (150)
Other income (expenses), net 212 92
Total other income (expenses), net 3,485 5,458
Net loss (42,607) (59,733)
Other comprehensive income (loss):    
Net unrealized gain (loss) on available-for-sale investments (452) 132
Net comprehensive loss $ (43,059) $ (59,601)
Net loss per share, basic (in dollars per share) $ (0.18) $ (0.28)
Net loss per share, diluted (in dollars per share) $ (0.18) $ (0.28)
Weighted-average number of shares used in computing net loss per share, basic (in shares) 240,290,782 215,358,619
Weighted-average number of shares used in computing net loss per share, diluted (in shares) 240,290,782 215,358,619